Apellis Pharmaceuticals, Inc. (APLS)
USD 19.83
(-11.94%)
USD 19.83
(-11.94%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 594.2 Million USD | 0.65% |
| 2022 | 590.34 Million USD | -13.58% |
| 2021 | 683.1 Million USD | -9.64% |
| 2020 | 756.01 Million USD | 112.95% |
| 2019 | 355.01 Million USD | 734.13% |
| 2018 | 42.56 Million USD | 28.24% |
| 2017 | 33.18 Million USD | 812.04% |
| 2016 | 3.63 Million USD | 13.71% |
| 2015 | 3.2 Million USD | 195.89% |
| 2014 | 1.08 Million USD | 59.76% |
| 2013 | 676.95 Thousand USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 640.15 Million USD | 13.25% |
| 2024 Q1 | 565.25 Million USD | -4.87% |
| 2024 Q3 | 664.74 Million USD | 3.84% |
| 2023 Q3 | 585.94 Million USD | 2.77% |
| 2023 Q4 | 594.2 Million USD | 1.41% |
| 2023 FY | 594.2 Million USD | 0.65% |
| 2023 Q1 | 566.74 Million USD | -4.0% |
| 2023 Q2 | 570.17 Million USD | 0.61% |
| 2022 Q2 | 668.08 Million USD | -2.27% |
| 2022 Q1 | 683.61 Million USD | 0.08% |
| 2022 FY | 590.34 Million USD | -13.58% |
| 2022 Q4 | 590.34 Million USD | 4.4% |
| 2022 Q3 | 565.47 Million USD | -15.36% |
| 2021 Q2 | 841.4 Million USD | 10.93% |
| 2021 Q3 | 583.01 Million USD | -30.71% |
| 2021 Q4 | 683.1 Million USD | 17.17% |
| 2021 FY | 683.1 Million USD | -9.64% |
| 2021 Q1 | 758.47 Million USD | 0.33% |
| 2020 Q3 | 662.49 Million USD | 3.83% |
| 2020 Q4 | 756.01 Million USD | 14.12% |
| 2020 FY | 756.01 Million USD | 112.95% |
| 2020 Q1 | 429.94 Million USD | 21.11% |
| 2020 Q2 | 638.04 Million USD | 48.4% |
| 2019 Q1 | 93.59 Million USD | 119.92% |
| 2019 FY | 355.01 Million USD | 734.13% |
| 2019 Q4 | 355.01 Million USD | 8.64% |
| 2019 Q3 | 326.79 Million USD | 107.33% |
| 2019 Q2 | 157.61 Million USD | 68.4% |
| 2018 Q2 | 37.26 Million USD | 9.09% |
| 2018 FY | 42.56 Million USD | 28.24% |
| 2018 Q4 | 42.56 Million USD | -1.46% |
| 2018 Q3 | 43.19 Million USD | 15.9% |
| 2018 Q1 | 34.16 Million USD | 2.93% |
| 2017 Q1 | - USD | -100.0% |
| 2017 Q3 | 6.93 Million USD | -78.78% |
| 2017 Q4 | 33.18 Million USD | 378.36% |
| 2017 FY | 33.18 Million USD | 812.04% |
| 2017 Q2 | 32.68 Million USD | 0.0% |
| 2016 Q1 | - USD | -100.0% |
| 2016 Q4 | 3.63 Million USD | 0.0% |
| 2016 FY | 3.63 Million USD | 13.71% |
| 2015 FY | 3.2 Million USD | 195.89% |
| 2015 Q4 | 3.2 Million USD | 20.47% |
| 2015 Q3 | 2.65 Million USD | 109.02% |
| 2015 Q2 | 1.27 Million USD | 0.0% |
| 2015 Q1 | 1.27 Million USD | 17.51% |
| 2014 FY | 1.08 Million USD | 59.76% |
| 2014 Q1 | - USD | 0.0% |
| 2014 Q4 | 1.08 Million USD | 0.0% |
| 2013 FY | 676.95 Thousand USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| AbCellera Biologics Inc. | 335.77 Million USD | -76.966% |
| Alkermes plc | 933.53 Million USD | 36.349% |
| Agenus Inc. | 462.29 Million USD | -28.535% |
| Alnylam Pharmaceuticals, Inc. | 4.05 Billion USD | 85.33% |
| Aptorum Group Limited | 5.25 Million USD | -11203.759% |
| Ardelyx, Inc. | 130.76 Million USD | -354.417% |
| Arrowhead Pharmaceuticals, Inc. | 478.39 Million USD | -24.21% |
| Bicycle Therapeutics plc | 224.41 Million USD | -164.785% |
| BioXcel Therapeutics, Inc. | 130.21 Million USD | -356.347% |
| ChromaDex Corporation | 26.5 Million USD | -2141.621% |
| Chimerix, Inc. | 19.74 Million USD | -2909.415% |
| Corbus Pharmaceuticals Holdings, Inc. | 35.17 Million USD | -1589.192% |
| Caribou Biosciences, Inc. | 72.56 Million USD | -718.842% |
| CRISPR Therapeutics AG | 346.76 Million USD | -71.356% |
| Precision BioSciences, Inc. | 140.92 Million USD | -321.664% |
| Dyadic International, Inc. | 2.34 Million USD | -25286.484% |
| Eton Pharmaceuticals, Inc. | 16.26 Million USD | -3553.748% |
| Fortress Biotech, Inc. | 165.93 Million USD | -258.089% |
| Lantern Pharma Inc. | 2.73 Million USD | -21588.977% |
| HOOKIPA Pharma Inc. | 71.48 Million USD | -731.294% |
| Inhibikase Therapeutics, Inc. | 3.52 Million USD | -16739.198% |
| Incyte Corporation | 1.59 Billion USD | 62.682% |
| IO Biotech, Inc. | 17.55 Million USD | -3284.649% |
| Jaguar Health, Inc. | 45.86 Million USD | -1195.533% |
| Novavax, Inc. | 2.57 Billion USD | 76.899% |
| Janux Therapeutics, Inc. | 36.05 Million USD | -1547.926% |
| Opthea Limited | 264.6 Million USD | -124.568% |
| Ligand Pharmaceuticals Incorporated | 130.7 Million USD | -354.611% |
| ContextLogic Inc. | 206 Million USD | -188.451% |
| MiMedx Group, Inc. | 96.33 Million USD | -516.847% |
| Pyxis Oncology, Inc. | 48.02 Million USD | -1137.368% |
| TransCode Therapeutics, Inc. | 3.52 Million USD | -16738.425% |
| NextCure, Inc. | 14.99 Million USD | -3862.186% |
| Ocuphire Pharma, Inc. | 4.04 Million USD | -14600.866% |
| Oncternal Therapeutics, Inc. | 6.67 Million USD | -8799.341% |
| Outlook Therapeutics, Inc. | 46.73 Million USD | -1171.334% |
| Vaxcyte, Inc. | 167.44 Million USD | -254.86% |
| PDS Biotechnology Corporation | 33.25 Million USD | -1686.604% |
| Madrigal Pharmaceuticals, Inc. | 235.21 Million USD | -152.625% |
| Pharming Group N.V. | 244.07 Million USD | -143.455% |
| Pieris Pharmaceuticals, Inc. | 11.92 Million USD | -4884.139% |
| Avidity Biosciences, Inc. | 127.79 Million USD | -364.985% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -8893.248% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -8893.248% |
| Sangamo Therapeutics, Inc. | 82.43 Million USD | -620.839% |
| Sol-Gel Technologies Ltd. | 6.64 Million USD | -8844.889% |
| Acelyrin, Inc. | 86.35 Million USD | -588.116% |
| Salarius Pharmaceuticals, Inc. | 1.29 Million USD | -45635.087% |
| SELLAS Life Sciences Group, Inc. | 14.37 Million USD | -4032.478% |
| Summit Therapeutics Inc. | 125.25 Million USD | -374.392% |
| Sensei Biotherapeutics, Inc. | 9.47 Million USD | -6168.689% |
| Senti Biosciences, Inc. | 52.57 Million USD | -1030.298% |
| Stoke Therapeutics, Inc. | 68.77 Million USD | -763.965% |
| Syros Pharmaceuticals, Inc. | 151.51 Million USD | -292.186% |
| Alaunos Therapeutics, Inc. | 1.95 Million USD | -30278.783% |
| Telomir Pharmaceuticals, Inc. Common Stock | 1.33 Million USD | -44391.241% |
| Entrada Therapeutics, Inc. | 226.83 Million USD | -161.96% |
| VistaGen Therapeutics, Inc. | 9.36 Million USD | -6243.643% |
| Wave Life Sciences Ltd. | 227.44 Million USD | -161.254% |
| Sorrento Therapeutics, Inc. | 494.5 Million USD | -20.161% |
| TRACON Pharmaceuticals, Inc. | 10.91 Million USD | -5344.466% |
| Barinthus Biotherapeutics plc | 27.51 Million USD | -2059.896% |
| Psyence Biomedical Ltd. | 12.1 Million USD | -4808.912% |
| Phathom Pharmaceuticals, Inc. | 486.6 Million USD | -22.114% |
| Immix Biopharma, Inc. | 3.72 Million USD | -15865.708% |
| Keros Therapeutics, Inc. | 37.81 Million USD | -1471.483% |
| MEI Pharma, Inc. | 8.35 Million USD | -7012.017% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | -1947.937% |
| Xeris Biopharma Holdings, Inc. | 347.58 Million USD | -70.956% |
| Rigel Pharmaceuticals, Inc. | 145.86 Million USD | -307.358% |
| Fortress Biotech, Inc. | 165.93 Million USD | -258.089% |
| Precigen, Inc. | 41.64 Million USD | -1326.878% |
| Clearside Biomedical, Inc. | 49.93 Million USD | -1090.084% |
| AlloVir, Inc. | 45.01 Million USD | -1220.024% |
| C4 Therapeutics, Inc. | 130.33 Million USD | -355.902% |
| Fate Therapeutics, Inc. | 137.8 Million USD | -331.211% |
| ImmuCell Corporation | 18.81 Million USD | -3058.162% |
| IDEAYA Biosciences, Inc. | 28.22 Million USD | -2005.183% |
| Onconetix, Inc. | 23.18 Million USD | -2463.357% |
| PureTech Health plc | 125.58 Million USD | -373.16% |
| VYNE Therapeutics Inc. | 8.95 Million USD | -6539.207% |
| Elevation Oncology, Inc. | 34.28 Million USD | -1633.297% |
| Kintara Therapeutics, Inc. | 2.44 Million USD | -24203.027% |
| Seer, Inc. | 39.36 Million USD | -1409.486% |
| Verrica Pharmaceuticals Inc. | 61.83 Million USD | -860.975% |
| Innoviva, Inc. | 568.55 Million USD | -4.513% |
| Aadi Bioscience, Inc. | 27.22 Million USD | -2082.345% |
| ESSA Pharma Inc. | 3.49 Million USD | -16901.343% |
| GlycoMimetics, Inc. | 6.9 Million USD | -8509.137% |
| GT Biopharma, Inc. | 6.63 Million USD | -8858.375% |
| Inhibrx Biosciences, Inc. | 264.39 Million USD | -124.747% |
| Akebia Therapeutics, Inc. | 272.28 Million USD | -118.229% |
| Catalyst Pharmaceuticals, Inc. | 84.02 Million USD | -607.173% |
| Longboard Pharmaceuticals, Inc. | 9.77 Million USD | -5979.486% |
| Orchestra BioMed Holdings, Inc. | 27.16 Million USD | -2087.085% |
| Alzamend Neuro, Inc. | 3.22 Million USD | -18320.67% |
| Rocket Pharmaceuticals, Inc. | 73.76 Million USD | -705.521% |
| Aptose Biosciences Inc. | 15.8 Million USD | -3658.747% |
| ZyVersa Therapeutics, Inc. | 11.03 Million USD | -5282.481% |
| Soligenix, Inc. | 7.27 Million USD | -8067.929% |
| Century Therapeutics, Inc. | 175.94 Million USD | -237.732% |
| Kura Oncology, Inc. | 51.66 Million USD | -1050.186% |
| TScan Therapeutics, Inc. | 121.28 Million USD | -389.94% |
| Intensity Therapeutics, Inc. | 4.13 Million USD | -14277.184% |
| Ocean Biomedical, Inc. | 6.61 Million USD | -8884.306% |
| CytomX Therapeutics, Inc. | 252.59 Million USD | -135.239% |
| Autolus Therapeutics plc | 263.9 Million USD | -125.158% |
| Mineralys Therapeutics, Inc. | 10.48 Million USD | -5568.851% |
| EyePoint Pharmaceuticals, Inc. | 88.86 Million USD | -568.695% |
| Eterna Therapeutics Inc. | 46.89 Million USD | -1166.997% |
| Adaptive Biotechnologies Corporation | 352.85 Million USD | -68.4% |
| GRI Bio, Inc. | 2.69 Million USD | -21932.221% |
| Xenetic Biosciences, Inc. | 809.58 Thousand USD | -73296.74% |
| Tenaya Therapeutics, Inc. | 31.09 Million USD | -1811.193% |
| IGM Biosciences, Inc. | 220.17 Million USD | -169.878% |
| INmune Bio, Inc. | 18.86 Million USD | -3050.297% |
| Heron Therapeutics, Inc. | 256.47 Million USD | -131.679% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -2130.363% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -21758.729% |
| Entero Therapeutics, Inc. | 3.28 Million USD | -18014.659% |
| Milestone Pharmaceuticals Inc. | 58.45 Million USD | -916.524% |
| X4 Pharmaceuticals, Inc. | 96.15 Million USD | -517.944% |
| Atara Biotherapeutics, Inc. | 264.73 Million USD | -124.454% |
| Coherus BioSciences, Inc. | 823.02 Million USD | 27.802% |
| Verastem, Inc. | 71.18 Million USD | -734.739% |
| Abeona Therapeutics Inc. | 49.17 Million USD | -1108.331% |
| Pliant Therapeutics, Inc. | 38.57 Million USD | -1440.279% |
| Tonix Pharmaceuticals Holding Corp. | 48.93 Million USD | -1114.357% |
| Histogen Inc. | 5.69 Million USD | -10330.209% |
| Aprea Therapeutics, Inc. | 4.38 Million USD | -13449.077% |
| Surrozen, Inc. | 8.14 Million USD | -7195.384% |
| Organovo Holdings, Inc. | 2.74 Million USD | -21523.326% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -189224.153% |
| Ovid Therapeutics Inc. | 56.22 Million USD | -956.749% |
| Panbela Therapeutics, Inc. | 16.51 Million USD | -3498.649% |
| CASI Pharmaceuticals, Inc. | 51.1 Million USD | -1062.767% |
| Cadrenal Therapeutics, Inc. Common Stock | 826.87 Thousand USD | -71762.011% |
| Centessa Pharmaceuticals plc | 126.72 Million USD | -368.896% |
| Hepion Pharmaceuticals, Inc. | 10.81 Million USD | -5395.021% |
| Arcturus Therapeutics Holdings Inc. | 150.88 Million USD | -293.805% |
| BioRestorative Therapies, Inc. | 2.6 Million USD | -22689.811% |
| Apollomics, Inc. | 14.15 Million USD | -4098.467% |
| Amarin Corporation plc | 279.58 Million USD | -112.531% |
| Mesoblast Limited | 188.79 Million USD | -214.733% |
| Turnstone Biologics Corp. | 14.14 Million USD | -4099.951% |
| Kymera Therapeutics, Inc. | 180.78 Million USD | -228.677% |
| Synaptogenix, Inc. | 5.52 Million USD | -10646.222% |
| Tiziana Life Sciences Ltd | 6.64 Million USD | -8838.162% |
| Aurinia Pharmaceuticals Inc. | 170.1 Million USD | -249.313% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -6843.971% |
| Monopar Therapeutics Inc. | 1.75 Million USD | -33711.959% |
| Exelixis, Inc. | 678.44 Million USD | 12.416% |
| Better Therapeutics, Inc. | 23.84 Million USD | -2392.278% |
| Nurix Therapeutics, Inc. | 164.04 Million USD | -262.221% |
| NLS Pharmaceutics AG | 10.68 Million USD | -5463.648% |
| Dermata Therapeutics, Inc. | 1.62 Million USD | -36497.878% |
| Aridis Pharmaceuticals, Inc. | 38.92 Million USD | -1426.47% |
| Gritstone bio, Inc. | 125.91 Million USD | -371.898% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -3948.848% |
| TNF Pharmaceuticals, Inc. | 5.08 Million USD | -11577.197% |
| Avid Bioservices, Inc. | 275.66 Million USD | -115.552% |
| Insmed Incorporated | 1.66 Billion USD | 64.242% |
| Virpax Pharmaceuticals, Inc. | 7.69 Million USD | -7622.994% |
| MediWound Ltd. | 27.18 Million USD | -2085.637% |
| OmniAb, Inc. | 87.4 Million USD | -579.873% |
| Alector, Inc. | 487.66 Million USD | -21.847% |
| Seres Therapeutics, Inc. | 403.45 Million USD | -47.28% |
| Checkpoint Therapeutics, Inc. | 18.42 Million USD | -3125.015% |
| Viracta Therapeutics, Inc. | 38.37 Million USD | -1448.508% |
| Zai Lab Limited | 240.17 Million USD | -147.405% |
| Revance Therapeutics, Inc. | 630.05 Million USD | 5.69% |
| Aura Biosciences, Inc. | 29.22 Million USD | -1933.082% |
| Lyell Immunopharma, Inc. | 95.07 Million USD | -524.977% |
| Immunic, Inc. | 25.36 Million USD | -2242.357% |
| Tarsus Pharmaceuticals, Inc. | 69.23 Million USD | -758.237% |
| Veracyte, Inc. | 93.71 Million USD | -534.033% |
| InMed Pharmaceuticals Inc. | 2.61 Million USD | -22608.569% |
| FibroGen, Inc. | 585.72 Million USD | -1.448% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -3318.334% |
| Adial Pharmaceuticals, Inc. | 653.07 Thousand USD | -90886.195% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.65 Million USD | -10406.824% |
| Jazz Pharmaceuticals plc | 7.65 Billion USD | 92.239% |
| Cyclacel Pharmaceuticals, Inc. | 8.19 Million USD | -7148.219% |
| Amylyx Pharmaceuticals, Inc. | 84.02 Million USD | -607.206% |
| TG Therapeutics, Inc. | 169.08 Million USD | -251.426% |
| Galecto, Inc. | 5.89 Million USD | -9978.172% |
| Calithera Biosciences, Inc. | 8.28 Million USD | -7072.972% |
| Fortrea Holdings Inc. | 2.61 Billion USD | 77.306% |
| KalVista Pharmaceuticals, Inc. | 28.82 Million USD | -1961.651% |
| Aptevo Therapeutics Inc. | 12.62 Million USD | -4608.098% |
| XBiotech Inc. | 8.39 Million USD | -6976.444% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -3948.848% |
| Lyra Therapeutics, Inc. | 53.18 Million USD | -1017.354% |
| Foghorn Therapeutics Inc. | 363.1 Million USD | -63.646% |
| Y-mAbs Therapeutics, Inc. | 26.88 Million USD | -2110.27% |
| Theravance Biopharma, Inc. | 169 Million USD | -251.595% |
| Ultragenyx Pharmaceutical Inc. | 1.21 Billion USD | 51.118% |
| Metagenomi, Inc. Common Stock | 500.42 Million USD | -18.741% |
| Vaxxinity, Inc. | 30.94 Million USD | -1820.272% |
| BioCryst Pharmaceuticals, Inc. | 972.48 Million USD | 38.898% |
| Gain Therapeutics, Inc. | 6.03 Million USD | -9752.404% |
| Cartesian Therapeutics, Inc. | 745.23 Million USD | 20.265% |
| NexImmune, Inc. | 5.08 Million USD | -11587.291% |
| Creative Medical Technology Holdings, Inc. | 371.39 Thousand USD | -159894.238% |
| Marker Therapeutics, Inc. | 3.07 Million USD | -19224.825% |
| Regeneron Pharmaceuticals, Inc. | 7.1 Billion USD | 91.639% |
| Chemomab Therapeutics Ltd. | 5.15 Million USD | -11429.017% |
| Scopus BioPharma Inc. | 7.45 Million USD | -7871.216% |
| RAPT Therapeutics, Inc. | 26.29 Million USD | -2159.865% |
| Ainos, Inc. | 7.39 Million USD | -7936.125% |
| Pluri Inc. | 34.11 Million USD | -1641.935% |
| Prothena Corporation plc | 135.01 Million USD | -340.099% |
| Adaptimmune Therapeutics plc | 243.1 Million USD | -144.427% |
| Celularity Inc. | 102.92 Million USD | -477.3% |
| Rallybio Corporation | 9.43 Million USD | -6197.255% |
| Cue Biopharma, Inc. | 24.44 Million USD | -2330.8% |
| MeiraGTx Holdings plc | 319.99 Million USD | -85.696% |
| Omeros Corporation | 403.25 Million USD | -47.354% |
| Humacyte, Inc. | 114.67 Million USD | -418.159% |
| Immunocore Holdings plc | 228.15 Million USD | -160.438% |
| Cocrystal Pharma, Inc. | 4.87 Million USD | -12088.903% |
| Cidara Therapeutics, Inc. | 76.74 Million USD | -674.315% |
| Blueprint Medicines Corporation | 918.64 Million USD | 35.317% |
| CalciMedica, Inc. | 4.02 Million USD | -14651.961% |
| Cabaletta Bio, Inc. | 17.45 Million USD | -3304.819% |
| Marinus Pharmaceuticals, Inc. | 154.14 Million USD | -285.492% |
| Scholar Rock Holding Corporation | 85.81 Million USD | -592.414% |
| Sana Biotechnology, Inc. | 277.79 Million USD | -113.904% |
| Pulmatrix, Inc. | 15.96 Million USD | -3622.414% |
| Elicio Therapeutics, Inc. | 15.77 Million USD | -3667.254% |
| Vigil Neuroscience, Inc. | 24.6 Million USD | -2314.895% |
| Intellia Therapeutics, Inc. | 250.8 Million USD | -136.918% |
| Adlai Nortye Ltd. American Depositary Shares | 50.78 Million USD | -1070.025% |
| Cytokinetics, Incorporated | 1.21 Billion USD | 50.918% |
| Eloxx Pharmaceuticals, Inc. | 31.78 Million USD | -1769.581% |
| Nutriband Inc. | 1.07 Million USD | -54974.477% |
| Protara Therapeutics, Inc. | 10.63 Million USD | -5488.348% |
| Vor Biopharma Inc. | 59.1 Million USD | -905.362% |
| Roivant Sciences Ltd. | 773.95 Million USD | 23.224% |
| Evogene Ltd. | 17.99 Million USD | -3202.996% |
| ProKidney Corp. | 29.21 Million USD | -1933.848% |
| Applied Therapeutics, Inc. | 71.97 Million USD | -725.531% |
| Hoth Therapeutics, Inc. | 704.98 Thousand USD | -84186.997% |
| BridgeBio Pharma, Inc. | 1.88 Billion USD | 68.542% |
| CorMedix Inc. | 11.91 Million USD | -4886.009% |
| BioLineRx Ltd. | 50.7 Million USD | -1071.964% |
| Tango Therapeutics, Inc. | 149.45 Million USD | -297.573% |
| Galectin Therapeutics Inc. | 88.44 Million USD | -571.871% |
| Atai Life Sciences N.V. | 49.16 Million USD | -1108.675% |
| Renovaro Biosciences Inc. | 31.15 Million USD | -1807.432% |
| Aerovate Therapeutics, Inc. | 17.96 Million USD | -3208.145% |
| Zentalis Pharmaceuticals, Inc. | 124.63 Million USD | -376.756% |
| Sagimet Biosciences Inc. | 5.65 Million USD | -10409.533% |
| MediciNova, Inc. | 3.89 Million USD | -15169.2% |
| Praxis Precision Medicines, Inc. | 18.27 Million USD | -3150.774% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -39402.247% |
| GeoVax Labs, Inc. | 3.51 Million USD | -16781.508% |
| Axsome Therapeutics, Inc. | 397.25 Million USD | -49.577% |
| Biomea Fusion, Inc. | 30.69 Million USD | -1836.165% |
| PTC Therapeutics, Inc. | 2.72 Billion USD | 78.168% |
| Mereo BioPharma Group plc | 15.96 Million USD | -3622.648% |
| Cullinan Oncology, Inc. | 31.2 Million USD | -1804.455% |
| Syndax Pharmaceuticals, Inc. | 58.68 Million USD | -912.557% |
| Absci Corporation | 58.3 Million USD | -919.156% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -3019.535% |
| 4D Molecular Therapeutics, Inc. | 32.06 Million USD | -1753.312% |
| Dyne Therapeutics, Inc. | 73.79 Million USD | -705.27% |
| Kiniksa Pharmaceuticals, Ltd. | 87.48 Million USD | -579.228% |
| Ventyx Biosciences, Inc. | 33.77 Million USD | -1659.577% |
| Allakos Inc. | 74.79 Million USD | -694.471% |
| Imunon, Inc. | 8.53 Million USD | -6865.759% |
| Fulcrum Therapeutics, Inc. | 22.5 Million USD | -2540.812% |
| Corcept Therapeutics Incorporated | 114.81 Million USD | -417.55% |
| BioAtla, Inc. | 48.98 Million USD | -1113.018% |
| NLS Pharmaceutics AG | 10.68 Million USD | -5463.648% |
| Bio-Path Holdings, Inc. | 2.77 Million USD | -21282.116% |
| Allogene Therapeutics, Inc. | 130.6 Million USD | -354.97% |
| Larimar Therapeutics, Inc. | 14.21 Million USD | -4080.155% |
| XOMA Corporation | 145.58 Million USD | -308.167% |
| Kezar Life Sciences, Inc. | 33.66 Million USD | -1665.065% |
| Cara Therapeutics, Inc. | 68.75 Million USD | -764.191% |
| aTyr Pharma, Inc. | 31.59 Million USD | -1780.587% |
| Aligos Therapeutics, Inc. | 61.82 Million USD | -861.146% |
| Akero Therapeutics, Inc. | 44.96 Million USD | -1221.492% |
| Viridian Therapeutics, Inc. | 48.4 Million USD | -1127.654% |
| Eliem Therapeutics, Inc. | 2.87 Million USD | -20604.146% |
| EyeGate Pharmaceuticals, Inc. | 8.15 Million USD | -7183.742% |
| Akari Therapeutics, Plc | 4.58 Million USD | -12862.675% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -3250.841% |
| Halozyme Therapeutics, Inc. | 1.64 Billion USD | 63.976% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -147014.937% |
| UroGen Pharma Ltd. | 243.52 Million USD | -144.005% |
| Sutro Biopharma, Inc. | 321.08 Million USD | -85.062% |
| ZIVO Bioscience, Inc. | 2.76 Million USD | -21417.165% |
| Orgenesis Inc. | 35.53 Million USD | -1572.18% |
| Entera Bio Ltd. | 1.37 Million USD | -42989.848% |
| GH Research PLC | 6.7 Million USD | -8767.468% |
| Lisata Therapeutics, Inc. | 6.8 Million USD | -8638.368% |
| Reneo Pharmaceuticals, Inc. | 18.82 Million USD | -3056.321% |
| Xencor, Inc. | 283.55 Million USD | -109.554% |
| 60 Degrees Pharmaceuticals, Inc. | 2.98 Million USD | -19801.999% |
| Replimune Group, Inc. | 113.21 Million USD | -424.855% |
| Coeptis Therapeutics Holdings, Inc. | 3.75 Million USD | -15715.524% |
| Vanda Pharmaceuticals Inc. | 103.53 Million USD | -473.949% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -147014.937% |
| Portage Biotech Inc. | 4.45 Million USD | -13253.011% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -39402.247% |
| Olema Pharmaceuticals, Inc. | 23.05 Million USD | -2477.913% |
| OncoCyte Corporation | 49.29 Million USD | -1105.341% |
| Qualigen Therapeutics, Inc. | 4.13 Million USD | -14263.96% |
| Processa Pharmaceuticals, Inc. | 797.48 Thousand USD | -74410.46% |
| Purple Biotech Ltd. | 10 Million USD | -5839.12% |
| CollPlant Biotechnologies Ltd. | 5.78 Million USD | -10169.772% |
| scPharmaceuticals Inc. | 57.26 Million USD | -937.72% |
| ProMIS Neurosciences, Inc. | 12.38 Million USD | -4696.642% |
| HilleVax, Inc. | 78.9 Million USD | -653.031% |
| NeuroSense Therapeutics Ltd. | 5.05 Million USD | -11666.515% |
| Tharimmune, Inc. | 1.81 Million USD | -32637.958% |
| Genprex, Inc. | 3.25 Million USD | -18159.712% |
| Neumora Therapeutics, Inc. Common Stock | 27.11 Million USD | -2091.117% |
| Atossa Therapeutics, Inc. | 5.23 Million USD | -11248.529% |
| XTL Biopharmaceuticals Ltd. | 206 Thousand USD | -288350.971% |
| Virios Therapeutics, Inc. | 358.54 Thousand USD | -165626.486% |
| OKYO Pharma Limited | 7.42 Million USD | -7907.295% |
| Savara Inc. | 37.19 Million USD | -1497.68% |
| Curis, Inc. | 57.61 Million USD | -931.398% |
| Daré Bioscience, Inc. | 26.32 Million USD | -2156.788% |
| Carmell Therapeutics Corporation | 39.19 Million USD | -1415.847% |
| Titan Pharmaceuticals, Inc. | 1.44 Million USD | -41050.208% |
| Achieve Life Sciences, Inc. | 20.81 Million USD | -2754.167% |
| BeiGene, Ltd. | 2.23 Billion USD | 73.399% |
| Kiromic BioPharma, Inc. | 21.28 Million USD | -2691.05% |
| Revolution Medicines, Inc. Warrant | 262.39 Million USD | -126.454% |
| Protagonist Therapeutics, Inc. | 21.27 Million USD | -2693.123% |
| Erasca, Inc. | 78.61 Million USD | -655.885% |
| bluebird bio, Inc. | 424.62 Million USD | -39.938% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -90584.042% |
| BioMarin Pharmaceutical Inc. | 1.89 Billion USD | 68.561% |
| DBV Technologies S.A. | 42.8 Million USD | -1288.339% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -90584.042% |
| Moderna, Inc. | 4.57 Billion USD | 87.003% |
| Vincerx Pharma, Inc. | 6.99 Million USD | -8394.768% |
| Fresh Tracks Therapeutics, Inc. | 1.65 Million USD | -35782.186% |
| Molecular Templates, Inc. | 31.17 Million USD | -1806.288% |
| Acrivon Therapeutics, Inc. Common Stock | 17.07 Million USD | -3381.013% |
| Travere Therapeutics, Inc. | 588.1 Million USD | -1.038% |
| Monte Rosa Therapeutics, Inc. | 124.5 Million USD | -377.257% |
| Spruce Biosciences, Inc. | 27.43 Million USD | -2065.721% |
| Celldex Therapeutics, Inc. | 36.45 Million USD | -1529.935% |
| Cogent Biosciences, Inc. | 55.63 Million USD | -968.049% |
| MacroGenics, Inc. | 154.2 Million USD | -285.332% |
| RenovoRx, Inc. | 4.46 Million USD | -13205.172% |
| Adicet Bio, Inc. | 37.12 Million USD | -1500.779% |
| Prime Medicine, Inc. | 60.78 Million USD | -877.639% |
| Aditxt, Inc. | 28.53 Million USD | -1982.638% |
| Adagene Inc. | 45.16 Million USD | -1215.514% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -328735.48% |
| Quantum-Si incorporated | 26.63 Million USD | -2131.268% |
| Maravai LifeSciences Holdings, Inc. | 697.56 Million USD | 14.817% |
| Acurx Pharmaceuticals, Inc. | 3.04 Million USD | -19430.686% |
| Voyager Therapeutics, Inc. | 114.96 Million USD | -416.879% |
| SciSparc Ltd. | 1.59 Million USD | -37154.483% |
| Vericel Corporation | 127.7 Million USD | -365.298% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -10577.813% |
| Minerva Neurosciences, Inc. | 85.35 Million USD | -596.137% |
| Generation Bio Co. | 171.63 Million USD | -246.215% |
| Astria Therapeutics, Inc. | 11.55 Million USD | -5044.667% |
| Black Diamond Therapeutics, Inc. | 41.83 Million USD | -1320.499% |
| Arcutis Biotherapeutics, Inc. | 252.69 Million USD | -135.146% |
| Invivyd, Inc. | 51.71 Million USD | -1049.051% |
| Relay Therapeutics, Inc. | 91.97 Million USD | -546.041% |
| Quoin Pharmaceuticals, Ltd. | 6.5 Million USD | -9034.298% |
| Spero Therapeutics, Inc. | 75.49 Million USD | -687.073% |
| Artelo Biosciences, Inc. | 1.02 Million USD | -58098.727% |
| 2seventy bio, Inc. | 310.12 Million USD | -91.602% |
| ADMA Biologics, Inc. | 193.97 Million USD | -206.331% |
| Clene Inc. | 38.95 Million USD | -1425.53% |
| Capricor Therapeutics, Inc. | 36.13 Million USD | -1544.511% |
| Boundless Bio, Inc. Common Stock | 256.97 Million USD | -131.231% |
| GeoVax Labs, Inc. | 3.51 Million USD | -16781.508% |
| Recursion Pharmaceuticals, Inc. | 190.26 Million USD | -212.309% |
| Citius Pharmaceuticals, Inc. | 12.17 Million USD | -4778.699% |
| Contineum Therapeutics, Inc. Class A Common Stock | 198.32 Million USD | -199.618% |
| Relmada Therapeutics, Inc. | 12.19 Million USD | -4772.642% |
| Finch Therapeutics Group, Inc. | 48.11 Million USD | -1135.079% |
| ALX Oncology Holdings Inc. | 52.84 Million USD | -1024.523% |
| Vir Biotechnology, Inc. | 369.85 Million USD | -60.66% |
| Evaxion Biotech A/S | 17.61 Million USD | -3272.838% |
| Ocular Therapeutix, Inc. | 160.92 Million USD | -269.237% |
| Verve Therapeutics, Inc. | 153.18 Million USD | -287.9% |
| Trevena, Inc. | 48.26 Million USD | -1131.215% |
| Surrozen, Inc. | 8.14 Million USD | -7195.384% |
| Tyra Biosciences, Inc. | 21.59 Million USD | -2651.605% |
| Cingulate Inc. | 10.36 Million USD | -5635.129% |
| Galmed Pharmaceuticals Ltd. | 2.75 Million USD | -21507.6% |
| Unity Biotechnology, Inc. | 37.29 Million USD | -1493.395% |
| Tenax Therapeutics, Inc. | 3.58 Million USD | -16467.843% |
| Terns Pharmaceuticals, Inc. | 13.15 Million USD | -4418.7% |
| ACADIA Pharmaceuticals Inc. | 317.2 Million USD | -87.329% |
| Connect Biopharma Holdings Limited | 24.84 Million USD | -2291.279% |
| Clearmind Medicine Inc. | 3.61 Million USD | -16360.047% |
| Kronos Bio, Inc. | 54.2 Million USD | -996.306% |
| Bolt Biotherapeutics, Inc. | 47.04 Million USD | -1163.119% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -2510.791% |
| Viking Therapeutics, Inc. | 20.07 Million USD | -2860.535% |
| Statera Biopharma, Inc. | 22.67 Million USD | -2520.379% |
| ImmunityBio, Inc. | 1.09 Billion USD | 45.505% |
| Korro Bio, Inc. | 51.75 Million USD | -1048.186% |
| Kineta, Inc. | 7.22 Million USD | -8127.762% |
| BioVie Inc. | 9.7 Million USD | -6024.521% |
| Codexis, Inc. | 49.94 Million USD | -1089.703% |
| Celularity Inc. | 102.92 Million USD | -477.3% |
| Crinetics Pharmaceuticals, Inc. | 96.24 Million USD | -517.379% |
| Celcuity Inc. | 51.45 Million USD | -1054.923% |
| Virax Biolabs Group Limited | 345.19 Thousand USD | -172037.696% |
| Cibus, Inc. | 206.11 Million USD | -188.287% |
| Eledon Pharmaceuticals, Inc. | 42.47 Million USD | -1298.962% |
| eFFECTOR Therapeutics, Inc. | 26.33 Million USD | -2156.004% |
| IN8bio, Inc. | 8.77 Million USD | -6673.928% |
| Kodiak Sciences Inc. | 213.59 Million USD | -178.199% |
| Annexon, Inc. | 47.11 Million USD | -1161.108% |
| Adverum Biotechnologies, Inc. | 89.54 Million USD | -563.617% |
| Assembly Biosciences, Inc. | 96.37 Million USD | -516.578% |
| Avalo Therapeutics, Inc. | 13.68 Million USD | -4240.777% |
| Ionis Pharmaceuticals, Inc. | 2.6 Billion USD | 77.176% |
| Eyenovia, Inc. | 19.78 Million USD | -2904.047% |
| Puma Biotechnology, Inc. | 177.08 Million USD | -235.548% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -7636.089% |
| Xilio Therapeutics, Inc. | 24.09 Million USD | -2365.7% |
| Arcellx, Inc. | 339.75 Million USD | -74.895% |
| Cardiff Oncology, Inc. | 11.89 Million USD | -4894.192% |
| Enanta Pharmaceuticals, Inc. | 245.54 Million USD | -142.001% |
| Regulus Therapeutics Inc. | 9.56 Million USD | -6113.625% |
| Moolec Science SA | 13.94 Million USD | -4160.981% |
| Acumen Pharmaceuticals, Inc. | 43.15 Million USD | -1277.014% |
| Geron Corporation | 146.12 Million USD | -306.639% |
| LAVA Therapeutics N.V. | 50.53 Million USD | -1075.906% |
| Royalty Pharma plc | 6.29 Billion USD | 90.564% |
| Atea Pharmaceuticals, Inc. | 39.77 Million USD | -1393.888% |
| Greenwich LifeSciences, Inc. | 294.4 Thousand USD | -201733.183% |
| TFF Pharmaceuticals, Inc. | 2.46 Million USD | -24052.069% |
| Mersana Therapeutics, Inc. | 189.15 Million USD | -214.137% |
| Humacyte, Inc. | 114.67 Million USD | -418.159% |
| Structure Therapeutics Inc. | 29.05 Million USD | -1945.399% |
| 89bio, Inc. | 59.96 Million USD | -890.959% |
| PMV Pharmaceuticals, Inc. | 26.46 Million USD | -2145.433% |
| Avenue Therapeutics, Inc. | 1.19 Million USD | -49583.027% |
| Genelux Corporation | 8.42 Million USD | -6957.114% |
| Trevi Therapeutics, Inc. | 6.85 Million USD | -8566.992% |
| Lexicon Pharmaceuticals, Inc. | 136.31 Million USD | -335.896% |
| Notable Labs, Ltd. | 4.42 Million USD | -13322.385% |
| Liquidia Corporation | 73.13 Million USD | -712.449% |
| Mustang Bio, Inc. | 17.61 Million USD | -3272.547% |
| Immunovant, Inc. | 48.95 Million USD | -1113.786% |
| Quantum-Si incorporated | 26.63 Million USD | -2131.268% |
| Arbutus Biopharma Corporation | 38.38 Million USD | -1448.105% |
| DiaMedica Therapeutics Inc. | 3.1 Million USD | -19049.5% |
| Vera Therapeutics, Inc. | 73.86 Million USD | -704.496% |
| Acasti Pharma Inc. | 11.55 Million USD | -5041.551% |
| MiNK Therapeutics, Inc. | 22.6 Million USD | -2528.344% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -21758.729% |
| Xenon Pharmaceuticals Inc. | 36.87 Million USD | -1511.327% |
| Elevai Labs, Inc. Common Stock | 1.36 Million USD | -43500.726% |
| NeuroBo Pharmaceuticals, Inc. | 6.09 Million USD | -9647.523% |
| Tempest Therapeutics, Inc. | 24.83 Million USD | -2292.627% |
| Soleno Therapeutics, Inc. | 23.18 Million USD | -2463.013% |
| PepGen Inc. | 34.63 Million USD | -1615.83% |
| Moleculin Biotech, Inc. | 12.14 Million USD | -4793.025% |
| United Therapeutics Corporation | 1.18 Billion USD | 49.737% |
| Nuvectis Pharma, Inc. | 6.98 Million USD | -8408.147% |
| Solid Biosciences Inc. | 38.45 Million USD | -1445.086% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -6843.971% |
| Immuneering Corporation | 12 Million USD | -4848.296% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -189224.153% |
| Silo Pharma, Inc. | 1.56 Million USD | -37765.313% |
| Belite Bio, Inc | 4.21 Million USD | -14010.876% |
| XOMA Corporation | 145.58 Million USD | -308.167% |
| ARS Pharmaceuticals, Inc. | 2.42 Million USD | -24373.188% |
| Bionomics Limited | 10.15 Million USD | -5749.25% |
| Apogee Therapeutics, Inc. | 21.49 Million USD | -2664.92% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -2493.327% |
| uniQure N.V. | 624.01 Million USD | 4.777% |
| Cassava Sciences, Inc. | 14.19 Million USD | -4086.044% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -328735.48% |
| Poseida Therapeutics, Inc. | 170.18 Million USD | -249.157% |
| Forte Biosciences, Inc. | 3.66 Million USD | -16108.647% |
| Anebulo Pharmaceuticals, Inc. | 260.58 Thousand USD | -227930.608% |
| Enlivex Therapeutics Ltd. | 6.74 Million USD | -8707.011% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -7636.089% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -3318.334% |
| FibroBiologics, Inc. Common Stock | 10.56 Million USD | -5522.72% |
| Altimmune, Inc. | 16.54 Million USD | -3492.34% |
| Amicus Therapeutics, Inc. | 617.7 Million USD | 3.804% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -2493.327% |
| Compugen Ltd. | 55.77 Million USD | -965.368% |
| Peak Bio, Inc. | 20.75 Million USD | -2763.194% |
| Zevra Therapeutics, Inc. | 110.46 Million USD | -437.926% |
| Benitec Biopharma Inc. | 4.96 Million USD | -11875.191% |
| Spyre Therapeutics, Inc. | 157.84 Million USD | -276.456% |
| NKGen Biotech, Inc. Common Stock | 75.17 Million USD | -690.445% |
| Zura Bio Limited | 21.29 Million USD | -2690.762% |
| PolyPid Ltd. | 17.46 Million USD | -3301.7% |
| Aileron Therapeutics, Inc. | 112.39 Million USD | -428.66% |
| NKGen Biotech, Inc. Warrants | 75.17 Million USD | -690.445% |
| Instil Bio, Inc. | 99.8 Million USD | -495.394% |
| argenx SE | 444.95 Million USD | -33.545% |
| Immunome, Inc. | 28.65 Million USD | -1973.449% |
| Compass Therapeutics, Inc. | 8.33 Million USD | -7027.372% |
| Verona Pharma plc | 58.84 Million USD | -909.855% |
| enGene Holdings Inc. Warrants | 14.47 Million USD | -4005.638% |
| Shattuck Labs, Inc. | 14.85 Million USD | -3898.984% |
| CervoMed Inc. | 2.59 Million USD | -22791.638% |
| LENZ Therapeutics, Inc. | 4.87 Million USD | -12091.403% |
| Plus Therapeutics, Inc. | 12.73 Million USD | -4565.586% |
| Dianthus Therapeutics, Inc. | 10.53 Million USD | -5540.332% |
| Moolec Science SA | 13.94 Million USD | -4160.981% |
| Enveric Biosciences, Inc. | 2.34 Million USD | -25255.579% |
| Inovio Pharmaceuticals, Inc. | 55.59 Million USD | -968.812% |
| AnaptysBio, Inc. | 364.28 Million USD | -63.116% |
| Design Therapeutics, Inc. | 11.95 Million USD | -4869.965% |
| Leap Therapeutics, Inc. | 12.68 Million USD | -4584.713% |
| NeurAxis, Inc. | 1.91 Million USD | -30965.869% |
| Seelos Therapeutics, Inc. | 38.92 Million USD | -1426.431% |
| Lumos Pharma, Inc. | 13.33 Million USD | -4356.679% |
| Achilles Therapeutics plc | 19.08 Million USD | -3013.161% |
| enGene Holdings Inc. Common Stock | 14.47 Million USD | -4005.638% |
| 180 Life Sciences Corp. | 5.38 Million USD | -10929.997% |
| Opiant Pharmaceuticals, Inc. | 23.58 Million USD | -2419.117% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -2510.791% |
| Nutriband Inc. | 1.07 Million USD | -54974.477% |
| ORIC Pharmaceuticals, Inc. | 30.59 Million USD | -1841.986% |
| CG Oncology, Inc. Common stock | 14.51 Million USD | -3994.887% |
| Fractyl Health, Inc. Common Stock | 401.27 Million USD | -48.081% |
| Rani Therapeutics Holdings, Inc. | 32.47 Million USD | -1729.856% |
| MoonLake Immunotherapeutics | 13.04 Million USD | -4453.641% |
| Palisade Bio, Inc. | 2.73 Million USD | -21594.378% |
| Tourmaline Bio, Inc. | 5.25 Million USD | -11211.803% |
| Beam Therapeutics Inc. | 478.38 Million USD | -24.211% |
| Neurogene Inc. | 36.54 Million USD | -1525.787% |
| Mirum Pharmaceuticals, Inc. | 397.95 Million USD | -49.317% |
| AEON Biopharma, Inc. | 159.88 Million USD | -271.638% |
| CARGO Therapeutics, Inc. Common Stock | 47.65 Million USD | -1147.028% |
| Sesen Bio, Inc. | 30.98 Million USD | -1817.793% |
| Enliven Therapeutics, Inc. | 25.96 Million USD | -2188.853% |
| Kiora Pharmaceuticals, Inc. | 7.6 Million USD | -7716.26% |
| Iovance Biotherapeutics, Inc. | 195.73 Million USD | -203.574% |
| Taysha Gene Therapies, Inc. | 192.05 Million USD | -209.392% |
| Athira Pharma, Inc. | 30.05 Million USD | -1876.94% |
| Vaccinex, Inc. | 5.94 Million USD | -9900.151% |
| HCW Biologics Inc. | 15.05 Million USD | -3847.723% |
| XOMA Corporation | 145.58 Million USD | -308.167% |
| Nektar Therapeutics | 267.04 Million USD | -122.512% |
| Arvinas, Inc. | 644.6 Million USD | 7.817% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -3250.841% |
| Merus N.V. | 102.15 Million USD | -481.697% |
| Omega Therapeutics, Inc. | 146.35 Million USD | -306.019% |
| Quince Therapeutics, Inc. | 95.12 Million USD | -524.694% |
| Rezolute, Inc. | 11.73 Million USD | -4963.994% |
| Clene Inc. | 38.95 Million USD | -1425.53% |
| Indaptus Therapeutics, Inc. | 2.84 Million USD | -20768.623% |
| BeyondSpring Inc. | 48.26 Million USD | -1131.036% |
| Synlogic, Inc. | 32.89 Million USD | -1706.381% |
| Allarity Therapeutics, Inc. | 14.61 Million USD | -3966.304% |
| Phio Pharmaceuticals Corp. | 1.63 Million USD | -36265.3% |
| Peak Bio, Inc. | 20.75 Million USD | -2763.194% |
| Werewolf Therapeutics, Inc. | 63.45 Million USD | -836.367% |
| Krystal Biotech, Inc. | 39.71 Million USD | -1396.22% |
| Karyopharm Therapeutics Inc. | 376.64 Million USD | -57.764% |
| SpringWorks Therapeutics, Inc. | 99.56 Million USD | -496.781% |
| Lipella Pharmaceuticals Inc. | 432.72 Thousand USD | -137217.61% |
| MannKind Corporation | 721.36 Million USD | 17.627% |
| Ikena Oncology, Inc. | 22.33 Million USD | -2560.439% |
| Cyclerion Therapeutics, Inc. | 2.08 Million USD | -28385.57% |
| Gyre Therapeutics, Inc. | 102.59 Million USD | -479.208% |
| Gossamer Bio, Inc. | 249.14 Million USD | -138.497% |
| CohBar, Inc. | 1.03 Million USD | -57387.147% |
| Cognition Therapeutics, Inc. | 10.68 Million USD | -5459.07% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -3019.535% |
| Legend Biotech Corporation | 589.93 Million USD | -0.725% |
| Mural Oncology plc | 37.92 Million USD | -1466.676% |
| Biora Therapeutics, Inc. | 132.63 Million USD | -348.0% |
| PaxMedica, Inc. Common Stock | 2.29 Million USD | -25787.715% |
| Disc Medicine, Inc. | 22.87 Million USD | -2497.635% |
| Champions Oncology, Inc. | 28.03 Million USD | -2019.526% |
| REGENXBIO Inc. | 262.22 Million USD | -126.6% |
| Ensysce Biosciences, Inc. | 3.35 Million USD | -17588.203% |
| Anavex Life Sciences Corp. | 12.53 Million USD | -4640.777% |
| Cellectar Biosciences, Inc. | 13.43 Million USD | -4323.954% |
| Edgewise Therapeutics, Inc. | 21.2 Million USD | -2702.212% |
| Vaxart, Inc. | 34.02 Million USD | -1646.389% |
| PharmaCyte Biotech, Inc. | 20.38 Million USD | -2814.323% |
| Aldeyra Therapeutics, Inc. | 28.53 Million USD | -1982.614% |
| Cellectis S.A. | 249.57 Million USD | -138.088% |
| Longeveron Inc. | 5.33 Million USD | -11033.764% |
| Repare Therapeutics Inc. | 41.81 Million USD | -1320.907% |
| Sarepta Therapeutics, Inc. | 2.4 Billion USD | 75.295% |
| Inozyme Pharma, Inc. | 60.36 Million USD | -884.311% |
| Revolution Medicines, Inc. | 262.39 Million USD | -126.454% |
| Nymox Pharmaceutical Corporation | 2.1 Million USD | -28101.661% |
| Third Harmonic Bio, Inc. | 8.62 Million USD | -6788.581% |
| ArriVent BioPharma, Inc. Common Stock | 11.8 Million USD | -4935.243% |
| AN2 Therapeutics, Inc. | 14.04 Million USD | -4131.354% |
| Anixa Biosciences, Inc. | 2.15 Million USD | -27524.779% |
| Vertex Pharmaceuticals Incorporated | 5.14 Billion USD | 88.462% |
| Denali Therapeutics Inc. | 122.96 Million USD | -383.242% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -10577.813% |
| Veru Inc. | 32.81 Million USD | -1710.911% |
| Corvus Pharmaceuticals, Inc. | 6.86 Million USD | -8550.59% |
| Cingulate Inc. | 10.36 Million USD | -5635.129% |
| Passage Bio, Inc. | 39.26 Million USD | -1413.446% |
| Context Therapeutics Inc. | 4.19 Million USD | -14075.797% |
| Exicure, Inc. | 8.54 Million USD | -6850.626% |
| Day One Biopharmaceuticals, Inc. | 29.5 Million USD | -1913.722% |
| Oramed Pharmaceuticals Inc. | 10.48 Million USD | -5566.689% |
| Scinai Immunotherapeutics Ltd. | 22.04 Million USD | -2595.926% |
| Rhythm Pharmaceuticals, Inc. | 162.98 Million USD | -264.577% |
| Nuvalent, Inc. | 31.82 Million USD | -1767.231% |
| ABVC BioPharma, Inc. | 6.36 Million USD | -9240.519% |
| Carisma Therapeutics, Inc. | 63.02 Million USD | -842.86% |
| Unicycive Therapeutics, Inc. | 18 Million USD | -3201.161% |
| OmniAb, Inc. | 87.4 Million USD | -579.873% |
| Anew Medical, Inc. | 8.24 Million USD | -7109.7% |
| Fennec Pharmaceuticals Inc. | 38.28 Million USD | -1451.901% |
| Lipocine Inc. | 2.63 Million USD | -22479.513% |
| Lexeo Therapeutics, Inc. Common Stock | 26.27 Million USD | -2161.758% |
| Nautilus Biotechnology, Inc. | 40.21 Million USD | -1377.691% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -2130.363% |
| G1 Therapeutics, Inc. | 86.15 Million USD | -589.706% |
| Bellerophon Therapeutics, Inc. | 5.4 Million USD | -10901.833% |
| Sage Therapeutics, Inc. | 82.74 Million USD | -618.103% |
| Ocugen, Inc. | 23.98 Million USD | -2377.626% |
| Mind Medicine (MindMed) Inc. | 46.4 Million USD | -1180.43% |
| Q32 Bio Inc. | 233.12 Million USD | -154.885% |
| Brainstorm Cell Therapeutics Inc. | 9.06 Million USD | -6454.258% |
| Alumis Inc. Common Stock | 53.5 Million USD | -1010.63% |
| Equillium, Inc. | 27.95 Million USD | -2025.439% |
| Kyverna Therapeutics, Inc. | 206.59 Million USD | -187.624% |
| Coya Therapeutics, Inc. | 5.62 Million USD | -10460.59% |
| CNS Pharmaceuticals, Inc. | 6.13 Million USD | -9588.767% |
| Galera Therapeutics, Inc. | 157.32 Million USD | -277.693% |
| Evelo Biosciences, Inc. | 69.43 Million USD | -755.802% |
| Comera Life Sciences Holdings, Inc. | 9.97 Million USD | -5857.46% |
| Dominari Holdings Inc. | 4.63 Million USD | -12720.043% |
| Edesa Biotech, Inc. | 1.84 Million USD | -32165.262% |
| vTv Therapeutics Inc. | 29.56 Million USD | -1909.703% |
| Bio-Techne Corporation | 744.34 Million USD | 20.17% |
| Agios Pharmaceuticals, Inc. | 126.09 Million USD | -371.224% |
| Harmony Biosciences Holdings, Inc. | 344.45 Million USD | -72.507% |
| Prelude Therapeutics Incorporated | 40.57 Million USD | -1364.471% |
| Candel Therapeutics, Inc. | 28.95 Million USD | -1952.039% |
| iTeos Therapeutics, Inc. | 92.36 Million USD | -543.362% |
| Nkarta, Inc. | 105.6 Million USD | -462.698% |
| BioCardia, Inc. | 4.59 Million USD | -12845.73% |
| Iterum Therapeutics plc | 32.66 Million USD | -1719.267% |